US Department of Veterans Affairs
876
12
18
754
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.6%
84 terminated/withdrawn out of 876 trials
90.0%
+3.5% vs industry average
14%
123 trials in Phase 3/4
43%
324 of 754 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (876)
Intensive Case Management Between VA and Community Care for Suicide Prevention
Role: collaborator
EMPOWER: Effects of Weight Loss and Exercise Post-stroke
Role: collaborator
Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis
Role: collaborator
Vestibulopathy as a Cause of Imbalance in Parkinson
Role: collaborator
Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors
Role: collaborator
Postcards to Improve Remote Monitoring Connectivity Among Veterans With a Disconnected Monitor
Role: collaborator
Engagement of Veterans With Lung Cancer
Role: collaborator
Pragmatic RCT of SBIRT-PM
Role: collaborator
Aging, Lifestyle and Inflammation in Veterans Exercising
Role: collaborator
Vestibulopathy, Imbalance, and Gait Disturbances in Parkinson Disease
Role: collaborator
Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients
Role: collaborator
Group Advanced Care Planning Pilot for Veterans
Role: collaborator
Sympathetic Overactivity in Post-traumatic Stress Disorder
Role: collaborator
Peripheral Nerve Blocks for Above-the-knee Amputations
Role: collaborator
Nicotinamide Riboside for Diabetic Neuropathy
Role: collaborator
Transforming Research and Clinical Knowledge in Geriatric Traumatic Brain Injury (TRACK-GERI)
Role: collaborator
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Role: collaborator
Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans
Role: collaborator
Supporting Health in Veterans With Heart Failure
Role: collaborator
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
Role: collaborator